Skip to main content
. 2016 Jul 15;1(4):230–236. doi: 10.1016/j.adro.2016.07.002

Table 3.

Late adverse events (CTCAE, version 3.0)

Toxicity Number of patients (n = 16)
≥Grade 3 (%)
Grade 1 Grade 2 Grade 3 Grade 4
Esophagitis 4 4 2 0 12.5
Pleural effusion 4 0 2 0 12.5
Pneumonitis 10 1 1 0 6.3
Pericardial effusion 3 0 1 0 6.3

CTCAE, Common Terminology Criteria for Adverse Events.